Abstract
Background
Separate reports from the maintenance treatment for late-life depression (MTLD) trials have shown that low socioeconomic status (SES) and anxiety symptoms at the time of treatment initiation predict lower levels of response to antidepressant treatment and higher levels of suicidal ideation in older adults.
Aim
To determine whether SES and anxiety independently contribute to worse treatment outcomes, as indicated by persistence of depressive symptoms during treatment and the persistence of suicidal ideation. Consistent with prior evidence that sociodemographic factors and clinical history are both prognostic of depression treatment efficacy, we hypothesized that SES and pre-existing anxiety symptoms will both predict lower levels of response to treatment and higher levels of suicidal ideation.
Method
Secondary analyses of data from the MTLD trials.
Results
Regression analyses which controlled for comorbid anxiety indicated that residents of middle- and high-income census tracts were more likely to respond to treatment (HR, 1.63; 95%CI, 1.08–2.46) and less likely to report suicidal ideation during treatment (OR, 0.51; 95%CI, 0.28–0.90) than residents of low income census tracts. The same regression models indicated that pre-existing anxiety symptoms were independently related to lower treatment response (HR, 0.73; 95%CI, 0.60–0.89) and higher risk of suicidal ideation (OR, 1.45; 95%CI, 0.98–2.14).
Conclusion
These findings demonstrate the importance of treating anxiety symptoms during the course of treatment for late-life depression and, at the same time, addressing barriers to treatment response related to low SES.
Similar content being viewed by others
References
Alexopoulos GS, Katz IR, Bruce ML, Heo M, Ten Have T, Raue P, Bogner HR, Schulberg HC, Mulsant BH, Reynolds CF 3rd (2005) Remission in depressed geriatric primary care patients: a report from the PROSPECT study. Am J Psychiatry 162:718–724
Andreescu C, Lenze EJ, Dew MA, Begley AE, Mulsant BH, Dombrovski AY, Pollock BG, Stack J, Miller MD, Reynolds CF (2007) Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. Br J Psychiatry 190:344–349
Arean PA, Gum AM, Tang L, Unutzer J (2007) Service Use and Outcomes Among Elderly Persons With Low Incomes Being Treated for Depression. Psychiatr Serv 58:1057–1064
Berkman LF, Macintyre S (1997) The measurement of social class in health studies: old measures and new formulations. IARC Sci Publ:51–64
Bernal M, Haro JM, Bernert S, Brugha T, de Graaf R, Bruffaerts R, Lepine JP, de Girolamo G, Vilagut G, Gasquet I, Torres JV, Kovess V, Heider D, Neeleman J, Kessler R, Alonso J (2007) Risk factors for suicidality in Europe: results from the ESEMED study. J Affect Disord 101:27–34
Blazer DG (2003) Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci 58:249–265
Braveman PA, Cubbin C, Egerter S, Chideya S, Marchi KS, Metzler M, Posner S (2005) Socioeconomic status in health research: one size does not fit all. JAMA 294:2879–2888
Brown GW, Harris TO (1978) Social origins of depression: A study of psychiatric disorder in women. Tavistock, London
Brown GW, Harris T (1986) Stressor, vulnerability and depression: a question of replication. Psychol Med 16:739–744
Brown GW, Bifulco A, Harris TO (1987) Life events, vulnerability and onset of depression: some refinements. Br J Psychiatry 150:30–42
Brugha TS, Bebbington PE, MacCarthy B, Sturt E, Wykes T, Potter J (1990) Gender, social support and recovery from depressive disorders: a prospective clinical study. Psychol Med 20:147–156
Casey PR, Dunn G, Kelly BD, Birkbeck G, Dalgard OS, Lehtinen V, Britta S, Ayuso-Mateos JL, Dowrick C (2006) Factors associated with suicidal ideation in the general population: five-centre analysis from the ODIN study. Br J Psychiatry 189:410–415
Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386–389
Cohen A, Houck PR, Szanto K, Dew MA, Gilman SE, Reynolds CFIII (2006) Social inequalities in response to antidepressant treatment in older adults. Arch Gen Psychiatry 63:50–56
Conwell Y, Duberstein PR, Caine ED (2002) Risk factors for suicide in later life. Biol Psychiatry 52:193–204
Cox DR (1972) Regression models and life-tables. J R Stat Soc: Ser B (Methodol) 34:187–220
Derogatis LR, Melisaratos N (1983) The Brief Symptom Inventory: an introductory report. Psychol Med 13:595–605
Dew MA, Reynolds CF 3rd, Houck PR, Hall M, Buysse DJ, Frank E, Kupfer DJ (1997) Temporal profiles of the course of depression during treatment: predictors of pathways toward recovery in the elderly. Arch Gen Psychiatry 54:1016–1024
Dohrenwend BP (2000) The role of adversity and stress in psychopathology: some evidence and its implications for theory and research. J Health Soc Behav 41:1–19
Dohrenwend BP, Dohrenwend BS (1969) Social status and psychological disorder; a causal inquiry. Wiley-Interscience, New York
Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM (1991) Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48:851–855
Griffin JM, Fuhrer R, Stansfeld SA, Marmot M (2002) The importance of low control at work and home on depression and anxiety: do these effects vary by gender and social class? Soc Sci Med 54:783–798
Gum AM, Arean PA, Bostrom A (2007) Low-income depressed older adults with psychiatric comorbidity: secondary analyses of response to psychotherapy and case management. Int J Geriatr Psychiatry 22:124–130
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Hirschfeld RM, Russell JM, Delgado PL, Fawcett J, Friedman RA, Harrison WM, Koran LM, Miller IW, Thase ME, Howland RH, Connolly MA, Miceli RJ (1998) Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine. J Clin Psychiatry 59:669–675
Hybels CF, Blazer DG, Steffens DC (2005) Predictors of partial remission in older patients treated for major depression: the role of comorbid dysthymia. Am J Geriatr Psychiatry 13:713–721
Isaacs SL, Schroeder SA (2004) Class - the ignored determinant of the nation’s health. N Engl J Med 351:1137–1142
Jeste ND, Hays JC, Steffens DC (2006) Clinical correlates of anxious depression among elderly patients with depression. J Affect Disord 90:37–41
Kendler KS, Karkowski LM, Prescott CA (1998) Stressful life events and major depression: risk period, long-term contextual threat, and diagnostic specificity. J Nerv Ment Dis 186:661–669
Kessler RC, Neighbors HW (1986) A new perspective on the relationships among race, social class, and psychological distress. J Health Soc Behav 27:107–115
Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS, National Comorbidity Survey R (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095–3105
Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005) Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:617–627
Kraemer HC, Wilson GT, Fairburn CG, Agras WS (2002) Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 59:877–883
Kraemer HC, Frank E, Kupfer DJ (2006) Moderators of treatment outcomes: clinical, research, and policy importance. JAMA 296:1286–1289
Lenze EJ (2003) Comorbidity of depression and anxiety in the elderly. Curr Psychiatry Rep 5:62–67
Lenze EJ, Mulsant BH, Shear MK, Schulberg HC, Dew MA, Begley AE, Pollock BG, Reynolds CF 3rd (2000) Comorbid anxiety disorders in depressed elderly patients. Am J Psychiatry 157:722–728
Link BG, Phelan JC (1995) Social conditions as fundamental causes of disease. J Health Soc Behav 35:80–94
Lorant V, Deliege D, Eaton W, Robert A, Philippot P, Ansseau M (2003) Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol 157:98–112
Lorant V, Croux C, Weich S, Deliege D, Mackenbach J, Ansseau M (2007) Depression and socio-economic risk factors: 7-year longitudinal population study. Br J Psychiatry 190:293–298
Marmot MG, Kogevinas M, Elston MA (1987) Social/economic status and disease. Annu Rev Public Health 8:111–135
Miranda J, Chung JY, Green BL, Krupnick J, Siddique J, Revicki DA, Belin T (2003) Treating depression in predominantly low-income young minority women. JAMA 290:57–65
Monroe SM, Simons AD (1991) Diathesis-stress theories in the context of life stress research: Implications for the depressive disorders. Psychol Bull 110:406–425
Mulder RT, Joyce PR, Frampton CM, Luty SE, Sullivan PF (2006) Six months of treatment for depression: outcome and predictors of the course of illness. Am J Psychiatry 163:95–100
Muntaner C, Eaton WW, Diala C, Kessler RC, Sorlie PD (1998) Social class, assets, organizational control and the prevalence of common groups of psychiatric disorders. Soc Sci Med 47:2043–2053
Reynolds CF 3rd, Frank E, Perel JM, Imber SD, Cornes C, Miller MD, Mazumdar S, Houck PR, Dew MA, Stack JA, Pollock BG, Kupfer DJ (1999) Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years. JAMA 281:39–45
Reynolds CF 3rd, Dew MA, Pollock BG, Mulsant BH, Frank E, Miller MD, Houck PR, Mazumdar S, Butters MA, Stack JA, Schlernitzauer MA, Whyte EM, Gildengers A, Karp J, Lenze E, Szanto K, Bensasi S, Kupfer DJ (2006) Maintenance treatment of major depression in old age. N Engl J Med 354:1130–1138
Rickels K, Jenkins BW, Zamostien B, Raab E, Kanther M (1968) Pharmacotherapy in neurotic depression: Differential population responses. J Nerv Ment Dis 145:475–485
Roberts RE, Lee ES (1993) Occupation and the prevalence of major depression, alcohol, and drug abuse in the United States. Environ Res 61:266–278
Ross LE, Campbell VLS, Dennis C-L, Blackmore ER (2006) Demographic Characteristics of Participants in Studies of Risk Factors, Prevention, and Treatment of Postpartum Depression. Can J Psychiatry 51:704–710
Schieman S, Plickert G (2007) Functional limitations and changes in levels of depression among older adults: a multiple-hierarchy stratification perspective. J Gerontol B Psychol Sci Soc Sci 62:S36–S42
Spillmann M, Borus JS, Davidson KG, Worthington JJ 3rd, Tedlow JR, Fava M (1997) Sociodemographic predictors of response to antidepressant treatment. Int J Psychiatry Med 27:129–136
Steffens DC, McQuoid DR (2005) Impact of symptoms of generalized anxiety disorder on the course of late-life depression. Am J Geriatr Psychiatry 13:40–47
Summerfelt WT, Meltzer HY (1998) Efficacy vs. effectiveness in psychiatric research. Psychiatr Serv 49:834–835
Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M, STAR*D Study Team (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. Am J Psychiatry 163:28–40
U.S. Census Bureau (2004) State and County QuickFacts: Allegheny County, Pennsylvania
Whyte EM, Dew MA, Gildengers A, Lenze EJ, Bharucha A, Mulsant BH, Reynolds CF (2004) Time course of response to antidepressants in late-life major depression: therapeutic implications. Drugs Aging 21:531–554
Wilson KC, Chen R, Taylor S, McCracken CF, Copeland JR (1999) Socio-economic deprivation and the prevalence and prediction of depression in older community residents. The MRC-ALPHA Study. Br J Psychiatry 175:549–553
Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121–130
Acknowledgments
This study was supported in part by grants P30 MH71944, RO1 MH43832, RO1 MH37869, R25 MH60473, P60 MD000207-03, and R03 MH083335 from the National Institute of Mental Health. Conflict of interest statement Dr. Reynolds receives research support (in the form of drug supplies only) from GlaxoSmithKline, Forest Pharmaceuticals, Pfizer, Eli Lilly & Co., and Bristol-Meyers Squibb for his NIH sponsored activities. The other authors do not have interests that might be affected by the publication of this paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cohen, A., Gilman, S.E., Houck, P.R. et al. Socioeconomic status and anxiety as predictors of antidepressant treatment response and suicidal ideation in older adults. Soc Psychiat Epidemiol 44, 272–277 (2009). https://doi.org/10.1007/s00127-008-0436-8
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00127-008-0436-8